The NeoVas® Bioabsorbable Sirolimus-Eluting Coronary Stent is a fully biodegradable scaffold that able to be gradually degrades, restoring the artery’s natural function without permanent implants.
Product features
Stent Platform
Fully degradable poly (L-lactide)
Sine wave structure in space, In-phase peak-valley connection
Drug coating
Fully degradable poly (D,L-lactide)
Effectively control sirolimusrelease rate
Delivery system
Completely self-developed second-generation rapid-exchange balloon dilatation catheter
Superior pushability and crossability
Drug
Classical Sirolimus with dose of 15.3 ug/mm
Inhibit the proliferation and migration of smooth muscle cells
Why choose NeoVas?
- Avoiding long-term safety problem associated with permanent retention of metal implants
- Avoiding imprisonment in the “metal cage” and recovering the vasomotor function
- Performing positive remodeling and bringing late benefits to the lumen
- Avoiding the risk of very late metal stent wire fracture
- Not hindering the option of revascularization, and facilitating re-interventional therapy
- Allowing MRI and CT examination at any time
- Solving the allergic reaction of some patients to metal stent
- Solving the psychological barrier of some patients rejecting the retention of foreign metal body
The NeoVas Bioabsorbable Sirolimus-Eluting Coronary Stent System consists of a degradable stent matrix, a degradable carrier, sirolimus, a developing platinum mark, and a balloon catheter. The structural diagram is shown above